BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 731,411 Value ($000) $5,551 Avg Close $8.33 Range $7.42 - $9.23
Q2 2025
Shares 143,312 Value ($000) $1,284 Avg Close $9.31 Range $6.02 - $11.31
Q3 2024
Shares 33,257 Value ($000) $253 Avg Close $7.60 Range $6.17 - $8.88
Q3 2023
Shares 134,362 Value ($000) $951 Avg Close $7.18 Range $6.62 - $7.95
Q1 2023
Shares 126,699 Value ($000) $1,057 Avg Close $9.63 Range $7.82 - $12.08
Q2 2022
Shares 35,574 Value ($000) $376 Avg Close $10.32 Range $7.61 - $18.00
Q1 2022
Shares 1,085,846 Value ($000) $17,656 Avg Close $16.04 Range $11.56 - $19.99
Q1 2021
Shares 182,905 Value ($000) $1,860 Avg Close $10.31 Range $7.27 - $14.24
Q2 2020
Shares 50,277 Value ($000) $239 Avg Close $3.99 Range $1.80 - $6.29
Q1 2020
Shares 71,660 Value ($000) $143 Avg Close $2.75 Range $1.58 - $4.35
Q2 2014
Shares 218,413 Value ($000) $2,785 Avg Close $9.73 Range $7.29 - $12.86